JournalsHub
.online
Find My Journal
LL

Lars Löfgren

AstraZeneca (Brazil) BR

ORCID 0000-0002-9207-1126
40
Publications
1,712
Citations
20
H-Index
22
i10-Index
10.5
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice.

K. Sigfridsson, Pia Skantze, Urban Skantze, L. Svensson, L. Löfgren - International journal of pharmaceutics, 2017
Cited by 21 Semantic Scholar

Uptake and distribution of intravenously or intravesically administered photosensitizers in the rat.

T. Windahl, Q. Peng, J. Moan, S. Hellsten, B. Axelsson - Cancer Letters, 1993
Cited by 17 Semantic Scholar

Airflows after inhalation of terbutaline sulphate aerosol from a 750-ml spacer for four weeks.

N. Eriksson, K. Hidinger, L. Rosenhall, H. Hagstad, L. Löfgren - Clinical Therapeutics, 1986
Cited by 0 Semantic Scholar

Research Topics

Pancreatic function and diabetes (8) Metabolism, Diabetes, and Cancer (7) Lipid metabolism and biosynthesis (6) Metabolomics and Mass Spectrometry Studies (5) Peroxisome Proliferator-Activated Receptors (4)

Affiliations

AstraZeneca (United Kingdom)
GB 2006 - 2006
AstraZeneca (Brazil)
BR 2026 - 2026
NGM Biopharmaceuticals (United States)
US 2026 - 2026
AstraZeneca (Finland)
FI 2026 - 2020
AstraZeneca (Sweden)
SE 2025 - 2006

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now